Estimate Recalculated Nov 7, 2024 05:13PM EST
Michael Mason has an estimated net worth of $8.59 Million. This is based on reported shares across multiple companies, which include ALNYLAM PHARMACEUTICALS, INC., and Karyopharm Therapeutics Inc..
Michael Mason's CIK is 0001514291
2018 was Michael Mason's most active year for acquiring shares with 15 total transactions. Michael Mason's most active month to acquire stocks was the month of November. 2013 was Michael Mason's most active year for disposing of shares, totalling 20 transactions. Michael Mason's most active month to dispose stocks was the month of November. 2018 saw Michael Mason paying a total of $2,804,910.51 for 46,196 shares, this is the most they've acquired in one year. In 2018 Michael Mason cashed out on 68,975 shares for a total of $4,876,007.21, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!